Clinical Trials · NCT06558422
Human Models of Selective Insulin Resistance: Pancreatic Clamp
- Phase
- Phase 1
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Columbia University
- Enrollment
- 36
- Start date
- Jan 2027
- Locations
- 1 site, United States
- Primary endpoint
- Hepatic de novo lipogenesis (DNL) (absolute value)